Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
32,982,385
-
Number of holders
-
289
-
Total 13F shares, excl. options
-
32,072,548
-
Shares change
-
+633,356
-
Total reported value, excl. options
-
$2,911,289,403
-
Value change
-
+$45,469,084
-
Put/Call ratio
-
400%
-
Number of buys
-
142
-
Number of sells
-
-127
-
Price
-
$90.79
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q4 2024
369 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q4 2024.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 289 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32,072,548 shares
of 32,982,385 outstanding shares and own 97% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3,216,120 shares), BlackRock, Inc. (3,203,464 shares), FIL Ltd (1,250,000 shares), Pentwater Capital Management LP (1,180,000 shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (1,034,812 shares), STATE STREET CORP (993,761 shares), NORGES BANK (914,864 shares), ALPINE ASSOCIATES MANAGEMENT INC. (888,120 shares), CITADEL ADVISORS LLC (872,962 shares), and Davidson Kempner Capital Management LP (861,572 shares).
This table shows the top 289 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.